Douglas Lee Charles, DO | |
105 W Main St, Valley View, PA 17983-9423 | |
(570) 682-8026 | |
(570) 682-8043 |
Full Name | Douglas Lee Charles |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 18 Years |
Location | 105 W Main St, Valley View, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285841106 | NPI | - | NPPES |
1023783600002 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OS014174 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Residential Home Health Of Nc Pa, Llc | Williamsport, PA | Home health agency |
Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
Geisinger Medical Center | Danville, PA | Hospital |
Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
Milton S Hershey Medical Center | Hershey, PA | Hospital |
Geisinger St. Luke's Hospital | Orwigsburg, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Family Practice Center Pc | 0244124212 | 265 |
News Archive
In 2016, an estimated 90 000 people died from measles - an 84% drop from more than 550 000 deaths in 2000 - according to a new report published today by leading health organizations. This marks the first time global measles deaths have fallen below 100 000 per year.
Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week's issue of The Lancet.
A team from the NUS Yong Loo Lin School of Medicine has invented a fundamentally new way of folding and protecting recombinant proteins.
A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade de Lisboa (FMUL) and Centro Hospitalar Lisboa Norte (CHLN) and collaborators at Instituto Português do Sangue e Transplantação (IPST), shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
› Verified 9 days ago
Entity Name | Family Practice Center Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154376937 PECOS PAC ID: 0244124212 Enrollment ID: O20040211000012 |
News Archive
In 2016, an estimated 90 000 people died from measles - an 84% drop from more than 550 000 deaths in 2000 - according to a new report published today by leading health organizations. This marks the first time global measles deaths have fallen below 100 000 per year.
Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week's issue of The Lancet.
A team from the NUS Yong Loo Lin School of Medicine has invented a fundamentally new way of folding and protecting recombinant proteins.
A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade de Lisboa (FMUL) and Centro Hospitalar Lisboa Norte (CHLN) and collaborators at Instituto Português do Sangue e Transplantação (IPST), shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Douglas Lee Charles, DO 7 Dock Hill Rd, Middleburg, PA 17842-8910 Ph: (570) 837-2123 | Douglas Lee Charles, DO 105 W Main St, Valley View, PA 17983-9423 Ph: (570) 682-8026 |
News Archive
In 2016, an estimated 90 000 people died from measles - an 84% drop from more than 550 000 deaths in 2000 - according to a new report published today by leading health organizations. This marks the first time global measles deaths have fallen below 100 000 per year.
Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week's issue of The Lancet.
A team from the NUS Yong Loo Lin School of Medicine has invented a fundamentally new way of folding and protecting recombinant proteins.
A new study led by Marc Veldhoen, principal investigator at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) with an interdisciplinary team of clinicians and researchers from Faculdade de Medicina da Universidade de Lisboa (FMUL) and Centro Hospitalar Lisboa Norte (CHLN) and collaborators at Instituto Português do Sangue e Transplantação (IPST), shows that 90% of subjects have detectable antibodies 40 days up to 7 months post contracting COVID-19.
Olympus, a global technology leader in delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today that two of its surgical products have been named finalists for an American Technology Award (ATA) in the Health and Medical Technologies category: ENDOEYE FLEX 3D and THUNDERBEAT.
› Verified 9 days ago